An Open, Randomized, Multicentre, Phase II Pilot Study

NCT00293085 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

37

Enrollment

OTHER

Sponsor class

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG: Docetaxel
DRUG: Docetaxel

Sponsor

Central European Cooperative Oncology Group